alexa Minimally Invasive Colorectal Surgery in the Morbidly Obese: Does High Body Mass Index Lead to Poorer Outcomes? | OMICS International
ISSN: 2161-1076
Surgery: Current Research

Like us on:

Make the best use of Scientific Research and information from our 700+ peer reviewed, Open Access Journals that operates with the help of 50,000+ Editorial Board Members and esteemed reviewers and 1000+ Scientific associations in Medical, Clinical, Pharmaceutical, Engineering, Technology and Management Fields.
Meet Inspiring Speakers and Experts at our 3000+ Global Conferenceseries Events with over 600+ Conferences, 1200+ Symposiums and 1200+ Workshops on
Medical, Pharma, Engineering, Science, Technology and Business

Minimally Invasive Colorectal Surgery in the Morbidly Obese: Does High Body Mass Index Lead to Poorer Outcomes?

Eric M Haas1,2*, Ali Aminian1,2, Javier Nieto1,2, Rodrigo Pedraza1,2, Carlos Martinez1,2, Chirag B Patel1,2 and Bartley Pickron T1,2

1Division of Minimally Invasive Colon and Rectal Surgery, Department of Surgery, The University of Texas Medical School at Houston, Houston, Texas, USA

2Colorectal Surgical Associates, Ltd, LLP, Houston, Texas, USA

*Corresponding Author:
Eric M Haas
Colorectal Surgical Associates, Ltd, LLP
7900 Fannin Street, Suite 2700, Houston, TX 77054, USA
Tel: 713-790-0600
Fax: 713-790-0616
E-mail: [email protected]

Received date: August 08, 2013; Accepted date: October 15, 2013; Published date: October 27, 2013

Citation: Haas EM, Aminian A, Nieto J, Pedraza R, Martinez C, et al. (2013) Minimally Invasive Colorectal Surgery in the Morbidly Obese: Does High Body Mass Index Lead to Poorer Outcomes? Surgery Curr Res 3:149. doi: 10.4172/2161-1076.1000149

Copyright: © 2013 Haas EM, et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

Visit for more related articles at Surgery: Current Research


Background: Obesity is associated with increased surgical risk and major abdominal procedures performed in morbidly obese patients may prove challenging when compared with normal weight patients. There are limited data regarding outcomes after minimally invasive colorectal surgery in morbidly obese patients. The aim of this study was to compare the outcomes between morbidly obese and normal weight patients.

Materials and Methods: Forty morbidly obese were matched to three normal weight patients (n=120), based on type of surgical approach and procedure. The patients underwent minimally invasive colorectal surgery by one of two colorectal surgeons. Patients were considered morbidly obese or normal-weight based on body mass index. Demographic data and operative outcomes were compared.

Results: Mean body mass index differed significantly between the morbidly obese (median 43.9 kg/m2) and normal weight (median 22.7 kg/m2) groups, p<0.00001. Both groups were comparable in regards to age, gender, history of prior abdominal operations, and clinical diagnosis. Surgical approaches included multiport laparoscopic colectomy (47.5%), hand-assisted laparoscopic colectomy (35%), robotic-assisted laparoscopic colectomy (12.5%), and single-incision laparoscopic colectomy (5%). The most common procedures were anterior resection (42.5%) and right hemicolectomy (40%). Morbidly obese patients required a significantly longer operative time (median 199 min vs. 139 min, p=0.0004) and resulted in significantly greater blood loss (median 100 cc vs. 75 cc, p=0.004), with no higher conversion rate to open surgery (7.5% vs. 2.5%, p=0.15) compared to normal weight patients. The mean length of hospital stay, 30-day postoperative complication, readmission, and reoperation rates were comparable between groups.

Conclusions: Minimally invasive surgery for the treatment of colorectal disorders in morbidly obese patients results in short-term outcomes comparable to those observed in normal weight patients. Although technically challenging, morbidly obese population may benefit from minimally invasive surgery in regard to enhanced recovery.


Minimally Invasive Surgery; Colorectal Surgery; Morbid Obesity; Colectomy


Obesity has become an increasing health concern in the United States, affecting more than a third of the adult population [1], with almost 1 in 20 Americans being morbidly obese as defined with body mass index (BMI) of 40 kg/m2 or greater [1,2]. The association between medical comorbidities (hypertension and diabetes mellitus) and obesity has been well established. Although obesity can lead to cardiovascular, metabolic, and pulmonary disease, it is additionally associated with an increased surgical risk and postoperative complication rate [3-6].

Minimally Invasive Surgery (MIS) for the treatment of colorectal diseases has been shown to provide several advantages over an open approach including decreased postoperative pain, improved pulmonary function, lower wound complication rate, and faster postoperative recovery resulting in shorter hospital stay [7,8]. Nevertheless, the impact of these advantages in the obese population has yet to be fully evaluated [9-11]. The available studies to date have compared outcomes of laparoscopic colectomy in obese patients (BMI>30 kg/m2) versus non-obese patients (BMI<30 kg/m2) including normal- and overweight patients, and have revealed higher conversion rate and worse postoperative outcomes in the obese patients [4,12,13]. However, the effect of MIS on the subset of patients who are morbidly obese (≥ 40 kg/ m2) has not been specifically addressed in the surgical literature [9]. The aim of this study was to compare short-term outcomes of minimally invasive colorectal surgery between Morbidly Obese (MO) and Normal Weight (NW) patients.

Materials and Methods

One thousand and eight consecutive patients underwent MIS for benign or malignant colorectal diseases between January 2006 and December 2011 in our practice. The surgical approach included Conventional Laparoscopic Colectomy (CLC), Hand-assisted Laparoscopic Colectomy (HALC), Robotic-assisted Laparoscopic Colectomy (RALC), and Single Incision Laparoscopic Colectomy (SILC). Of these cases, 40 patients were MO using BMI as an objective parameter to categorize body weight in accordance with the WHO classification, BMI ≥ 40 kg/m2. These cases were each randomly matched with three cases involving NW patients (18.5 kg/m2≤ BMI <25 kg/m2, n=120 NW cases) based on two matching criteria: type of MIS approach and type of colorectal procedure.

Demographic data, intraoperative parameters, and postoperative outcomes were collected and entered prospectively into an Institutional Review Board-approved database for retrospective analysis. Demographic data including age, gender, BMI, American Society of Anesthesiologist (ASA) score and history of prior abdominal surgery were tabulated. Intraoperative parameters including Estimated Blood Loss (EBL), Total Operative Time (OT), and conversion rate were analyzed. Postoperative outcomes including length of hospital stay (LOS), complication rate, readmission rate, and reoperation rate were assessed. Each procedure was performed by one of two board-certified colorectal surgeons (E. M. H. and T. B. P.) and the operative technique for the different minimally invasive procedures has been previously described [14-21].

Data were analyzed using Stata (StataCorp LP, College Station, TX). Continuous parameters are presented as mean ± standard deviation, or median and range. Categorical data are expressed as frequency (%). Comparative analysis was performed with Student’s t-test for normally-distributed continues variables, Wilcoxon rank-sum test for non-normally distributed continuous variables, and chi-square or Fisher’s exact tests for categorical variables. Logistic regression analysis was performed to determine odds ratios. P<0.05 was considered to be statistically significant.


The median BMI for the MO and NW groups was 43.9 kg/m2 (range 40-61.8 kg/m2) and 22.7 kg/m2 (range 18.5-24.9 kg/m2), respectively (p<0.00001). There was no significant difference between the groups in regards to age (p=0.15), gender (p=1), history of prior abdominal operations (p=0.12), and surgeon distribution (p=0.08). The ASA score was significantly greater in the MO group (2.8 ± 0.5) compared to the NW group (2.3 ± 0.6), p=0.0001 (Table 1). The colorectal MIS approaches included multiport CLC (47.5%), HALC (35%), RALC (12.5%), and SILC (5%). The groups did not differ in terms of clinical diagnosis (p=0.47) or presence of malignancy on histopathologic examination (p=0.93). The most common procedure was anterior resection (42.5%), followed by right hemicolectomy (40%), left colectomy (5%), low anterior resection (5%), abdominoperineal resection (5%), and subtotal colectomy (2.5%) (Table 2).

Parameters Morbid obesity (n=40) Normal weight (n=120) p-value
Gender (F, %) 23 (57.5%) 69 (57.5%) 1
Age (years) 56.3 ± 11.0 60.0 ± 15.1 0.15
BMI (kg/m2) 44.6 ± 4.6 22.5 ± 1.9 N/A
median, range 43.9, 40-61.8 22.7, 18.5-24.9 <0.00001*
ASA score 2.8 ± 0.5 2.3 ± 0.6 0.0001*
Prior abdominal surgeries (%) 23 (57.5%) 52 (43.3%) 0.12
Surgeon distribution     0.08
E.M.H. (%) 25 (62.5%) 92 (76.7%)  
T.B.P. (%) 15 (37.5%) 28 (23.3%)  

Table 1: Preoperative characteristics.

Parameters Morbid obesity (n=40) Normal weight (n=120) p-value
Clinical diagnosis (%)     0.47
Cancer 14 (35%) 47 (39%)  
Polyp 14 (35%) 24 (20%)  
Diverticulitis    10 (25%) 37 (31%)  
Crohn’s disease 1 (2.5%) 4 (3%)  
Ulcerative colitis 1 (2.5%) 5 (4%)  
Rectal prolapse 0 3 (3%)  
Surgical approach (%)     1
Conventional LC 19 (47.5%) 57 (47.5%)  
Hand-assisted LC 14 (35%) 42 (35%)  
Robotic-assisted LC 5 (12.5%) 15 (12.5%)  
Single-incision LC 2 (5%) 6 (5%)  
Operative procedure (%)     1
Right colectomy 16 (40%) 48 (40%)  
Left colectomy 2 (5%) 6 (5%)  
Anterior resection 17 (42.5%) 51 (42.5%)  
Low anterior resection 2 (5%) 6 (5%)  
Abdomino-perineal resection 2 (5%) 6 (5%)  
Subtotal colectomy 1 (2.5%) 3 (2.5%)  
Pathology (%)     0.93
Malignant 23 (57.5%) 70 (58%)  
Benign 17 (42.5%) 50 (42%)  

Table 2: Diagnosis and operations.

In regard to the intraoperative parameters, the MO group had a significantly longer OT (median 199 min) compared to the NW group (median 139 min), p=0.0004. There was significantly greater blood loss in the MO group (median 100 ml) compared to the NW group (median 75 ml), p=0.004 (Table 3). There was no significant difference in intraoperative complication rate (7.5% in the MO group and 4.2% in the NW group, p=0.40). There was no significant difference in the rate of conversion to open surgery between the MO and NW groups (7.5% vs. 2.5% respectively, p=0.15). However, the odds ratio of conversion from any non-HALC approach to HALC was 14 for MO compared to NW patients, p=0.02. In the subset of converted patients to HALC, no significant difference was observed in the LOS (4.8 ± 1.9 vs. 4.6 ± 4.6, p=0.94) or complication rate (20% vs. 22.2%, p=1).

Parameters Morbid obesity (n=40) Normal weight (n=120) p-value
Operative time (min) 203.8 ± 88.8 149.2 ± 63.2 N/A
median, range 199, 70-420 139, 70-420 0.0004*
Estimated blood loss (ml) 223.75 ± 467.3 115.5 ± 164.2 N/A
median, range 100, 25-3000 75, 25-1200 0.004*
Complications (%) 3 (7.5%) 5 (4.2%) 0.40
Bleeding (%) 2 (5%) 3 (2.5%) 0.60
Bladder injury (%) 1 (2.5%) 0 0.25
Ureteral injury (%) 0 1 (0.8%) 1
Bowel thermal injury (%) 0 1 (0.8%) 1
Conversion to open (%) 3 (7.5%) 3 (2.5%) 0.15
Failure to progress (%) 1 (2.5%) 2 (1.7%)  
Bleeding (%) 1 (2.5%) 0  
Presence of large colonic mass (%) 1 (2.5%) 0  
Presence of large ovarian mass (%) 0 1 (0.8%)  
Conversion to Hand-assisted LC (%) 4/26 (15.4%) 1/78 (1.3%) 0.004*
Failure to progress (%) 3 (11.5%) 1 (1.3%)  
Inability to maintain pneumoperitoneum (%) 1 (3.8%) 0  

Table 3: Intraoperative data.

The hospital LOS was comparable between the two groups (median 4 days in the MO group and 3 days in the NW group), p=0.08. The overall postoperative complication rate was greater in the MO group (30%) compared to the NW group (17.5%), but did not reach statistical significance (p=0.09). The most frequent complications encountered in the MO and NW groups were prolonged ileus (7.5% vs. 4.2%, respectively, p=0.41), wound infection (5% vs. 0.8%, respectively, p=0.15), and anastomotic leak (2.5% vs. 1.7%, respectively, p=1) (Table 4). Reoperation within 30 days was necessary in 1 MO patient (2.5%) and 6 NW patients (5%), p=0.50. The most frequent indication for reoperation was anastomotic leak (n=3 cases). Overall two of the abdominal reoperations (33.3%) were performed with MIS approach. The 30-day readmission rate was comparable between the MO group (12.5%) and NW group (8.3%), p=0.43. There was one 30-day postoperative mortality in the NW group (0.8%) and none in the MO group (p=1).

Parameters Morbid obesity (n=40) Normal weight (n=120) p-value
Complications (%) 12 (30%) 21 (17.5%) 0.09
Prolonged ileus (%) 3 (7.5%) 5 (4.2%) 0.41
Wound infection (%) 2 (5%) 1 (0.8%) 0.15
Anastomotic leak (%) 1 (2.5%) 2 (1.7%) 1
Abdominal/pelvic abscess (%) 1 (2.5%) 2 (1.7%) 1
Deep vein thrombosis (%) 1 (2.5%) 0 0.25
Length of stay (days) 4.9 ± 3.4 5.1 ± 5.6 N/A
median, range 4, 2-20 3, 2-40 0.08
30-day Readmission Rate (%) 5 (12.5%) 10 (8.3%) 0.43
30-day Reoperation Rate (%) 1 (2.5%) 6 (5%) 0.50
Mortality (%) 0 1 (0.8%) 1

Table 4: Postoperative data.


With 35.7% of the American population categorized as such, obesity is now considered an epidemic [1,2,22]. Even more alarming is the prevalence of morbid obesity which is increasing at a rate twice as fast as obesity [2]. The medical conditions associated with obesity (e.g., hyperlipidemia, diabetes mellitus, and cardiovascular disease) are well-recognized co morbid factors that can negatively impact operative outcomes [5,6]. In those who are morbidly obese, these co morbid conditions may be even more profound. In a recent study involving the American College of Surgeons National Surgical Quality Improvement Program (ACS-NSQIP) dataset, MO patients who underwent open colon resection for malignant disease had a significantly higher risk of surgical site infection (20.7% vs. 9.0%), dehiscence (3.3% vs. 1.1%), pulmonary embolism (1.3% vs. 0.3%), and renal failure (3.0% vs. 1.5%) when compared with NW patients, respectively [23].

Minimally invasive colorectal surgery is now widely accepted as a surgical approach for both malignant and benign colorectal diseases with advantages that may be more pronounced in high-risk patients [7,8]. Although studies regarding the role of the MIS approach in the treatment of colorectal diseases in obese patients have been published [4,6,10-12,24-27], feasibility and safety of MIS in the subset of patients with MO is not widely reported [9]. Mustain et al. [27] reviewed a multi-institutional NSQIP dataset to determine the effect of BMI on outcomes following minimally invasive colorectal surgery and noted a positive correlation between OT and BMI class, independent of other variables. Obesity was also an independent risk factor for superficial wound infection; however, major morbidity and mortality rates were similar among the groups [27]. In a recent comprehensive metaanalysis evaluating the impact of obesity on Perioperative outcomes after minimally invasive colorectal surgery (the analysis included one study involving MO patients), obesity was associated with longer OT and higher rates of conversion to open surgery secondary to limited exposure of the operative field and difficult dissection. However, a negative impact of obesity on intraoperative blood loss, perioperative mortality and reoperation rate was not observed [6].

Khoury et al. [9] compared the short-term outcomes following LC between 36 MO patients and 36 control patients with BMI<30 kg/m2 and found comparable results in regards to OT(177.9 ± 89.1 min vs. 136.4 ± 71.3 min, p=0.12), EBL (222.3 ± 196.4 ml vs. 157.1 ± 140.7 ml, p=0.1), conversion rate (13.9% vs. 8.3%, p=0.7), median LOS (4.5 days vs. 4 days, p=0.2), and postoperative complication rate (27.8% vs. 47.2%, p=0.14), respectively [9]. In the current study, we aimed to explore the benefits and limitations of the minimally invasive platform in the MO subset of high-risk patients to determine the feasibility and utility of this approach. On average the operative time was 54.6 min longer in the MO patients compared to the NW patients. This result is consistent with the abovementioned studies and was largely due to loss of abdominal domain, poor exposure and a relatively confined operative field of view. We encountered technical challenges with retraction of the characteristic shortened and thickened small bowel and colonic mesentery and considerable limitations in the ability to tilt the table to extreme angles for optimal utilization of gravitational forces. Furthermore, the MO patients tended to be sensitive to elevated peak airway pressures with even moderate Trendelenburg, necessitating frequent interruption of the procedures to provide normalization of pressures.

Despite the greater intraoperative blood loss, prolonged operative times and anatomical challenges, there was no overall significant difference between the groups in regards to conversion to open procedures. During the course of the study, HALC was noted to be an excellent platform to overcome many of the limitations in exposure and positioning by using the surgeon’s hand as a large retractor. The odds ratio of conversion to HALC was 14 for MO compared to NW patients. The main reason for conversion was failure to progress secondary to restricted and inadequate exposure. In the subset of converted patients to HALC, no significant difference was observed in the LOS or complication rate. Similar results have been observed in other studies involving a mixed population in which those converted to HALC recovered in a similar fashion to those who did not; whereas those converted to open fared poorly [19,28].

Considering that the MO patients are classified as high-risk when compared to NW patients, one would expect a higher rate of complications, prolonged LOS, and a greater incidence of reoperation and readmissions [4,12,13] in the MO group. In this study however, the incidence of postoperative complication rate, including wound infection as well as the reoperation rate, was not found to be significantly higher in the MO patients. Furthermore, LOS, readmission rate, and mortality rate were comparable between the MO and NW groups. Thus, performing minimally invasive colon resection surgery in the MO may serve as an equalizer in regards to postoperative outcomes since the outcomes approach those in the NW group.

To our knowledge this is the largest matched case-control study to address the effects of morbid obesity on the surgical outcomes of MIS for colorectal diseases. To minimize the effect of confounding factors, each MO patient was matched with three NW patients based on two matching criteria: type of MIS approach and type of colorectal procedure. However, this study is limited by the retrospective design and the relatively small number of patients of a single surgical service, which may account for differences in complication rates not reaching statistical significance. Furthermore, selection bias could have had an effect because BMI>40 kg/m2 corresponded with greater ASA score, which could account for an expectation of higher complication rates in the MO cohort. However, the observed complication rates results in this study may reflect the positive impact of advantages of MIS when utilized in the population of MO patients.

In conclusion, minimally invasive surgery for the treatment of colorectal disorders in MO patients results in short-term outcomes comparable to those observed in NW patients. Although MIS is a technically challenging procedure in the MO population, it may benefit this high-risk population in regard to enhanced recovery. Comparative analysis and larger cohorts of patients will be necessary to enumerate the extent of the benefits and limitations in MO patients.


EMH was responsible for the conception and design of this manuscript. EMH, AM, JN, RP, CM, CBP and TBP were responsible for drafting the manuscript, revising it critically for important intellectual content, and providing final approval.

Funding Support

There are no funding sources or financial relationships to disclose.


Poster presentation at the meeting of The American Society of Colon and Rectal Surgeons, San Antonio, TX, June 2-6, 2012.


Select your language of interest to view the total content in your interested language
Post your comment

Share This Article

Relevant Topics

Article Usage

  • Total views: 11792
  • [From(publication date):
    December-2013 - May 21, 2018]
  • Breakdown by view type
  • HTML page views : 8032
  • PDF downloads : 3760

Post your comment

captcha   Reload  Can't read the image? click here to refresh

Peer Reviewed Journals
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals
International Conferences 2018-19
Meet Inspiring Speakers and Experts at our 3000+ Global Annual Meetings

Contact Us

Agri & Aquaculture Journals

Dr. Krish

[email protected]

1-702-714-7001Extn: 9040

Biochemistry Journals

Datta A

[email protected]

1-702-714-7001Extn: 9037

Business & Management Journals


[email protected]

1-702-714-7001Extn: 9042

Chemistry Journals

Gabriel Shaw

[email protected]

1-702-714-7001Extn: 9040

Clinical Journals

Datta A

[email protected]

1-702-714-7001Extn: 9037

Engineering Journals

James Franklin

[email protected]

1-702-714-7001Extn: 9042

Food & Nutrition Journals

Katie Wilson

[email protected]

1-702-714-7001Extn: 9042

General Science

Andrea Jason

[email protected]

1-702-714-7001Extn: 9043

Genetics & Molecular Biology Journals

Anna Melissa

[email protected]

1-702-714-7001Extn: 9006

Immunology & Microbiology Journals

David Gorantl

[email protected]

1-702-714-7001Extn: 9014

Materials Science Journals

Rachle Green

[email protected]

1-702-714-7001Extn: 9039

Nursing & Health Care Journals

Stephanie Skinner

[email protected]

1-702-714-7001Extn: 9039

Medical Journals

Nimmi Anna

[email protected]

1-702-714-7001Extn: 9038

Neuroscience & Psychology Journals

Nathan T

[email protected]

1-702-714-7001Extn: 9041

Pharmaceutical Sciences Journals

Ann Jose

[email protected]

1-702-714-7001Extn: 9007

Social & Political Science Journals

Steve Harry

[email protected]

1-702-714-7001Extn: 9042

© 2008- 2018 OMICS International - Open Access Publisher. Best viewed in Mozilla Firefox | Google Chrome | Above IE 7.0 version
Leave Your Message 24x7